Systems biology of cisplatin resistance: past, present and future

The platinum derivative cis-diamminedichloroplatinum(II), best known as cisplatin, is currently employed for the clinical management of patients affected by testicular, ovarian, head and neck, colorectal, bladder and lung cancers. For a long time, the antineoplastic effects of cisplatin have been fu...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Lorenzo Galluzzi, Ilio Vitale, Judith Michels, Catherine Brenner, György Szabadkai, Annick Harel‐Bellan, Maria Castedo, Guido Kroemer
Hōputu: Revisão
Reo:Ingarihi
I whakaputaina: 2014
Urunga tuihono:https://doi.org/10.1038/cddis.2013.428
https://www.nature.com/articles/cddis2013428.pdf
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!